Disrupted metabolic function in people with alcohol use disorder (AUD) may be amplified in the context of obesity, contributing to intensified alcohol cravings, according to a preliminary study that supports ongoing investigation of GLP-1 agonists as a potential AUD treatment.
This article was originally published on MedicalXpress.com

